Article

Ophthalmology organizations voice concerns to FDA on contact lens safety

Key recommendations presented to the FDA by ophthalmic organizations to improve contact lens safety included improving contact lens product testing and advocating universal lens care guidelines for consumers.

Washington, DC-Key recommendations presented to the FDA by ophthalmic organizations to improve contact lens safety included improving contact lens product testing and advocating universal lens care guidelines for consumers. The American Academy of Ophthalmology (AAO), the Contact Lens Association of Ophthalmologists, the Cornea Society, and the American Society of Cataract and Refractive Surgery were represented at the meeting.

The number of cases of microbial keratitis, particularly Acanthamoeba keratitis, among contact lens wearers remains steady, despite attempts to improve contact lens disinfection regimens and voluntary recalls of contact lens solutions, according to specialists.

"Now is the time to tighten the safety net around contact lens products," said Elmer Tu, MD, AAO spokesperson and director of the cornea and external disease service at the University of Illinois, Chicago. "While improved testing and consumer awareness of lens care guidelines may not prevent future outbreaks of eye infections, they will provide an important additional layer of safety for contact lens wearers."

A concern that some ophthalmologists still have is the practice of "passive verification" of contact lens prescriptions. Through this system, third-party sellers (such as online vendors) of contact lenses notify eye-care professionals (ECPs) of customer requests to purchase contact lenses. Unless the ECP notifies the seller within 8 business hours that the prescription is incorrect, expired, or otherwise problematic, the seller may presume that the prescription is correct and then complete the sale.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.